The new 1H-furo[3,2-b]imidazo[4,5-d]pyridine derivatives are selective Jak1 kinase inhibitors useful in treating disorders related to Jak1 activities such as autoimmune diseases or disorders, inflammatory diseases or disorders, and cancer or neoplastic diseases or disorders.
新型 1H-
呋喃并[3,2-b]
咪唑并[4,5-d]
吡啶衍生物是一种选择性 Jak1 激酶
抑制剂,可用于治疗与 Jak1 活性有关的疾病,如自身免疫性疾病或紊乱、炎症性疾病或紊乱以及癌症或肿瘤性疾病或紊乱。